Long-Term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. J of Skin 2021, 5 (6), s44. https://doi.org/10.25251/skin.5.supp.44.